Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO00626) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Copper histidine
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 3 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=151722"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Induced by This Xenobiotics | ||||||
| HMG-CoA reductase (HMGCR) | DME Info | Homo sapiens | [1] | |||
| Metallothionein-2A (MT2A) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Physiological copper exposure in Jurkat cells induces changes in the expression of genes encoding cholesterol biosynthesis proteins. Biometals. 2013 Dec;26(6):1033-40. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.